Early identification and standardization of clinical diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathology. The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans.
Treatment and management of Leigh syndrome requires individualized treatment plans, typically including drug treatment, rehabilitation, regular follow-up, and multi-dimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of NDUFS associated with Leigh syndrome. The platform serves a team of internationally recognized experts in the field of genetic metabolism in China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.